News


News

Zellkraftwerk/Canopy Biosciences: Immune Profiling Platform continues to grow

The German-American company Zellkraftwerk / Canopy Biosciences merged with another partner in the USA at the end of 2019 and announced the acquisition of Core Diagnostics. The company is one of the leading CLIA-certified providers of biomarker analysis services for biopharmaceutical research.
More